Correlation Between Genmab AS and Orsted AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Orsted AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Orsted AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Orsted AS, you can compare the effects of market volatilities on Genmab AS and Orsted AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Orsted AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Orsted AS.

Diversification Opportunities for Genmab AS and Orsted AS

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Genmab and Orsted is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Orsted AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orsted AS and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Orsted AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orsted AS has no effect on the direction of Genmab AS i.e., Genmab AS and Orsted AS go up and down completely randomly.

Pair Corralation between Genmab AS and Orsted AS

Assuming the 90 days trading horizon Genmab AS is expected to under-perform the Orsted AS. But the stock apears to be less risky and, when comparing its historical volatility, Genmab AS is 1.73 times less risky than Orsted AS. The stock trades about -0.18 of its potential returns per unit of risk. The Orsted AS is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  41,050  in Orsted AS on September 4, 2024 and sell it today you would lose (2,910) from holding Orsted AS or give up 7.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Orsted AS

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Orsted AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orsted AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Orsted AS is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Genmab AS and Orsted AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Orsted AS

The main advantage of trading using opposite Genmab AS and Orsted AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Orsted AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orsted AS will offset losses from the drop in Orsted AS's long position.
The idea behind Genmab AS and Orsted AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device